Story of
Emergen

Emergen Life Sciences (Private) Limited was established in the year 2012 with the vision of contributing towards a long felt need to Research, Develop and Manufacture much required pharmaceutical preparations within Sri Lanka.

Profile of
Emergen

We remain firm in our conviction that our people matter the most. Such outlook no doubt has contributed to the success of the enterprise. Although considered a little stringent by industry standards, enticing individuals with abilities beyond mere book learning remains a prime goal of the company. We remain happy with the multi task orientation of the talents at hand. It gives us the confidence to take challenges head-on, be they difficult formulations or processes that are difficult to master.

Products of Emergen

Salhale 200

Salhale 400

Beclohale 200

Beclohale 400

Formohale 200

Formohale 400

Flutihale 250

Flutihale 500

Iprahale 40

Tiohale 18

Biclofen SR 75

Biclofen SR 100

Fungizap 100

Formoforte 400

Metanase NS 50

Slickhaler

Aerohaler

Skyhaler

Soft Air Plus

Budehale NS 64

Flutihale NS 50

Beclohale NS 50

Emprez 20

Emprez 40

Pantaprez 20

Pantaprez 40

Uriflo

Letricet 5

More about Emergen

Scope of Emergen

Having identified Asthma and COPD as of special significance due to the prevalence of such diseases in the country, research initially focused on powder inhalation preparations with a view to broad-base the options available to the healthcare providers dependent on imported formulations.

Facility of Emergen

EMERGEN considers quality to be of paramount importance. The processes within the manufactory are geared towards delivering the best to the prescribers and patients. Being mindful of sustaining the strides made by the company in venturing into a challenging area of pharmaceutical manufacture, EMERGEN leaves no stone unturned in maintaining above par standards in all key areas of the manufacturing process.

Achievements

EMERGEN gained recognition both nationally and internationally for a unique process for the manufacture of powder inhalation formulations. The researchers were aiming at achieving above par lung deposition for a capsule based inhalation powder when used in conjunction with a novel inhalation device.

Story of Emergen

Profile of Emergen